Schonfeld Group Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Schonfeld Group Holdings’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$778K	Sell	6,900 -56,400	-89%	-$6.12M	0.49%	55
2015 Q3	$6.4M	Buy	63,300 +32,700	+107%	+$3.92M	3.34%	6
2015 Q2	$3.76M	Buy	+30,600	New	+$3.66M	3.47%	12
2014 Q2	–	Sell	-16,800	Closed	-$1.32M	–	184
2014 Q1	$1.32M	Buy	+16,800	New	+$1.4M	0.33%	68

Other funds holding IBB

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Schonfeld Group Holdings's IBB Position: Q4 2015 in Review

Schonfeld Group Holdings reduced its iShares Biotechnology ETF (IBB) stake by 89% in Q4 2015, selling an estimated $6.12M and leaving 6,900 shares worth $778K. The position accounts for 0.49% of the portfolio, ranked #55.

Schonfeld Group Holdings first reported a position in IBB in Q1 2014 and has held it in 4 quarters since. The position peaked at $6.4M in Q3 2015. 431 funds tracked by Wall St. Rank hold IBB as of Q4 2015.

Schonfeld Group Holdings held 6,900 shares of iShares Biotechnology ETF worth $778K as of Q4 2015.
Schonfeld Group Holdings sold 56,400 iShares Biotechnology ETF shares in Q4 2015, an estimated $6.12M.
iShares Biotechnology ETF made up 0.49% of Schonfeld Group Holdings's portfolio in Q4 2015, its #55 holding.
Schonfeld Group Holdings first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 4 quarters since.
Schonfeld Group Holdings's iShares Biotechnology ETF position peaked at $6.4M in Q3 2015.
431 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.